Summary
We report a 45-year-old female who had symptomatic gastrointestinal involvement, eosinophils in the cellular infiltrate, and who proved to havel-tryptophan-associated eosinophilia-myalgia syndrome. This case illustrates that gastrointestinal disease can be a major, seemingly primary clinical presentation in this syndrome, and that a drug history, specificallyl-tryptophan, needs to be included in the differential diagnosis of “eosinophilic gastroenteritis.”
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Eosinophilia-myalgia syndrome andl-tryptophan-containing products—New Mexico, Minnesota, Oregon, and New York, 1989. MMWR 38:785–788, 1989
Kilbourne EM, Swygert LA, Philen RM, Sun RK, Auerbach SB, Miller L, Nelson DE, Falk H: Interim guidance on the eosinophilic-myalgia syndrome. Ann Int Med 112:85–87, 1990 (editorial)
Hertzman PA, Blevins WL, Mayer, J, Greenfield B, Ting M, Gleich GJ: Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 322:869–873, 1990
Varga J, Heinman-Patterson TD, Emery DL, Griffin R, Lally EV, Uitto JJ, Jimenez SA: Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome: Semin Arthritis Rheum 19:313–328, 1990
Hsu SM, Raine L, Fanger H: Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580, 1981
Tai PC, Spry CJ, Peterson C, Venge P, Olsson T: Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 309:182–184, 1984
Update: Eosinophilia myalgia associated with ingestion ofl-tryptophan—United States, as of January 9, 1990. JAMA 265:633, 1990
Madara JL, Carlson S: Supraphysiologicl-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epitheliumin vitro. J Clin Invest 87:454–462, 1991
De Schryver-Kecskemeti K, Gramlich TL, Crofford LJ, Rader JI, Page SW, Needham LL, Hill RH Jr, Sternberg EM: Mast cell and eosinophil infiltrates in gastrointestinal mucosa of Lewis rats treated withl-tryptophan implicated in human eosinophilia myalgia syndrome. Modern Pathol 4:354–357, 1991
Varga J, Peltonen J, Uitto J, Jimenez SA: Development of diffuse fasciitis with eosinophilia duringl-tryptophan treatment: Demonstration of elevated type I collagen gene expression in affected tissues (A clinicopathologic study of four patients). Ann Intern Med 112:344–351, 1990
Clauw DJ, Danshel DJ, Umhau A, Katz P: Tryptophanassociated eosinophilic connective-tissue disease (a new clinical entity?) JAMA 263:1502–1506, 1990
Owen WF, Petersen J, Sheff DM, Folkerth RD, Anderson RJ, Corson JM, Sheffer AL, Austen KF: Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc Natl Acad Sci USA 87:8647–8651, 1990
Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR: Eosinophilic gastroenteritis: A clinical pathological study of patients with disease of the mucosa, muscle layer and subserosal tissues. Gut 31:54–58, 1990
De Schryver-Kecskemeti K, Clouse RE: A previously unrecognized subgroup of “eosinophilic gastroenteritis”: That associated with connective tissue disease. Am J Surg Pathol 8:171–180, 1984
Case records of the Massachusetts General Hospital (Case 4-1990). N Engl J Med 322:252–261, 1990
Freundlich B, Werth VP, Rook AH, O'Connor CR, Schumacher HR, Leyden JJ, Stolley PD:l-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med 112:758–762, 1990
Gordon ML, Lebwohl MG, Phelps RG, Cohen SR, Fleischmajer R: Eosinophilic fasciitis associated with tryptophan ingestion. Arch Dermatol 127:217–220, 1991
Varga J, Griffin R, Newman JH, Jimenez SA: Eosinophilic fasciitis is clinically distinguishable from the eosinophiliamyalgia syndrome and is not associated withl-tryptophan use. J Rheumatol 19:259–263, 1991
Kilbourne EM, Rigau-Perez JG, Heath CW Jr, Zack MM, Falk H, Martin-Marcos M, de Carlos A: Clinical epidemiology of toxic-oil syndrome: Manifestation of a new illness. N Engl J Med 309:1408–1414, 1983
Bern MJ, Sturbaum CW, Karayalcin SS, Berschneider HM, Wachsman JT, Powell DW: Immune system control of rat and rabbit colonic electrolyte transport: Role of prostaglandins and enteric nervous system. J Clin Invest 83:1810–1820, 1989
Perdue MH, Chung M, Gall DG: Effect of intestinal anaphylaxis on gut function in the rat. Gastroenterology 86:391–397, 1984
De Schryver-Kecskemeti K, Clouse RE: Perineural/intraneural inflammatory infiltrates in the intestines of patients with systemic connective tissue disease. Arch Pathol Lab Med 113:394–398, 1989
Cohen S, Laufer I, Snape WJ, Yih-Ju S, Levine GM, Jimens S: The gastrointestinal manifestations of scleroderma: Pathogenesis and management. Gastroenterology 79:155–166, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Schryver-Kecskemeti, K., Bennert, K.W., Cooper, G.S. et al. Gastrointestinal involvement inl-tryptophan (l-trp) associated eosinophilia-myalgia syndrome (EMS). Digest Dis Sci 37, 697–701 (1992). https://doi.org/10.1007/BF01296424
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296424